Gå till innehåll

Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal

Immunoglobulin

Summary

Risk. The use of amino acids, proteins and peptides is not considered to have any environmental impact.

 

Even though biomolecules are exempted they should still be regarded as biologically active.

 

This summary information comes from Fass.se. The information about biomolecules comes from Fass environmental information from Grifols Nordic.

Detailed information

Fass environmental information

Fass miljöinformation for Flebogamma DIF (immunglobulin, human normal) from Grifols Nordic, Cutaquig (immunglobulin, human normal) from Octapharma Nordic and Beriglobin (immunglobulin, human normal) from CSL Behring (downloaded 2024-02-01).

According to the European Medicines Agency guideline on environmental risk assessments for pharmaceuticals (EMA/CHMP/SWP/4447/00), vitamins, electrolytes, amino acids, peptides, proteins, carbohydrates, lipids proteins, vaccines and herbal medicinal products are exempted because they are unlikely to result in significant risk to the environment.

Grifols Nordic also has the following information: Even though biomolecules, such as vaccines and hormones, are exempted they should still be regarded as biologically active.

References

  1. Fass för vårdpersonal.
  2. European Medicines Agency, EMA: Committee for Medicinal Products for Human Use (CHMP). Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use. 1 June 2006.

Author: Health and Medical Care Administration, Region Stockholm